The Use Of F-18-Fluoroestradiol (Fes) And F-18-Fluorodeoxyglucose (Fdg) Pet In The Evaluation Of Breast Cancer Heterogeneity.

Lanell M. Peterson,Brenda F. Kurland,Alena Novakova,Jean H. Lee,Jennifer M. Specht,Mark Muzi,Perrin Romine,Vicky Wu,David A. Mankoff,Paul Kinahan,Hannah M. Linden

Journal of Clinical Oncology（2017）

引用 0|浏览6

暂无评分

摘要

11572Background: 18F-Fluoroestradiol (FES) is an estrogen analogue that has been shown to be a promising biomarker in ER imaging of breast cancer. FES uptake correlates to ER expression, provides q...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要